Analytes of clinical biochemistry and hematology in COVID-19

Czech version

Authors: B. Friedecký ¹; J. Kratochvíla ²
Authors‘ workplace: Ústav klinické biochemie a diagnostiky Fakultní nemocnice, Hradec Králové ¹; SEKK spol. s r. o., Pardubice ²
Published in: Klin. Biochem. Metab., 29, 2021, No. 1, p. 25-30

Overview

Minireview deals with possibilities of use of routine biochemical and haematological analytes for monitoring patients with COVID-19. Communication contents information on the changes some analytes (mainly CRP, ferritin, D-dimer,

procalcitonin, lymphocytes, LD and many more). We assessed magnitudes of their changes during therapy of disease and for their prediction potential to discrimination of severity, fatality and survivability in this disease. Text is based on the recommendations from Task Force IFCC on COVID-19 and we used also results of some longitudinal and metaanalytic studies. In this communication are introduced some aspects of harmonization levels in analytes used for given purpose.

Keywords:

COVID-19 – routine analytes – Biochemistry – haematology – recommendations

Sources

Thompson, S., Bohn, M. K., Mancini, N., Loh, T. P., Wang, C. B. et al. IFCC Interim Guidelines on biochemical/hematological monitoring of COVID-19 patients. Clin. Chem. Lab. Med., 2020, 58(7), s. 2009-2016.
Bohn, M. K., Lippi, G., Horvath, A., Sethi, S., Koch, D. et al. Molecular, serological and biochemical diagnosis and monitoring of COVID-19: IFCC Task Force Evaluation of the latest evidence. Clin. Chem. Lab. Med., 2020, 58(7), s. 1037-1052.
Sandoval, Y., Januzzi, J. L., Jaffé, A. S. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC Review Topic of the Week. J Am. Coll. Cardiol., 2020, 76(10), s. 1244-1258.
Lala, A., Johnson, K. W., Januzzi, J. L., Rusaak, A. J., Paranjpe, I. et al. Prevalence and impact of myocardial injury in patients with COVID-19 infection. J Am. Coll. Cardiol., 2020, 76(5), s. 533-546.
Khourssaji, M., Chapelle, V., Evenepoel, A., Belkhir, L., Yombi, J. C. et al. A biological profile for diagnosis and outcome of COVID-19 patients. Clin. Chem. Lab. Med., 2020, 58(12), s. 2141-2150.
Santotoribio, J. D., Nuňez-Jurado, D., Lepe-Balsalobre, E. Evaluation of routine blood tests for diagnosis of suspected coronavirus disease 2020. Clin. Lab., 2020, 66(9), DOI:10.7754/Clin.Lab.2020.200522.
JCTLM Database Newsletter: June 2020, [online] [cit. 2020-12-10]. Dostupné na: <https://www.bipm.org/jctlm>
Lippi, G., Plebani, M. Procalcitonin in patiens with severe coronavirus dinase 2019 (COVID-19). A metaanalysis. Clin. Chim. Acta, 2020, 505, s. 190-191.
Lippi, G., Plebani, M., Henry, B. M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections. Clin. Chim. Acta, 2020, 506, s. 145-148.
Mattiuzzi, C., Lippi, G. Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID-19). J Med. Virol., 2020, DOI: 10.1002/jmv.26385.
Aloisio, E., Serafini, L., Chibireva, M., Dolci, A., Panteghini, M. Hypoalbuminemia and elevated D-dimer in COVID-19 patients: A call for result harmonization. Clin. Chem. Lab. Med., 2020, 58(11), e255-e256.
Chambliss, A. B., Hayden, J., Colby, J. M. Evaluation of procalcitonin immunoassay concordance near clinical decision point. Clin. Chem. Lab. Med., 2019, 57(9), s. 1414-1421.
Dupuy, A. M., Bargnoux, A. S., Montagnon, S., Kuster, N., Badiou, S. et al. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay. Scand. J Clin. Lab. Invest., 2020, s. 541-545, DOI:10.1080/00365513.2020.1804071.
Kavsak, P. A., Hammarsten, O., Worster, A., Smith, S. W., Apple, F. S. Cardiac troponin testing in patients with COVID-19. Clin. Chem., 2020, 67(1), s. 107-113.
Asghar, M. S., Kazmi, S. J. H., Khan, N. A., Akram, N., Hassan, M. et al. Poor prognostic biochemical markers predicting fatalities caused by COVID-19: A retrospective observational study from a developing country. Cureus, 2020, 12(8), e9575.
Malik, P., Patel, U., Mehta, D., Patel, M., Kelkar, R. et al. Biomarkers and outcomes of COVID-19 hospitalizations: systematic review and meta-analysis. BMJ Evid. Based Med., 2020, DOI:10.1036/bnjebm.2020.111536.
Zeng, H. L., Lu, Q. B., Yang, Q., Wang, X., Yue, D. Y. Longitudinal profile of laboratory parameters and their application in the prediction of fatal outcome among patients with SARS-CoV-2. A retrospective cohort study. Clin. Infect. Dis., 2020, DOI:10.1093/cid/caa574.
Lippi, G., Henry, B. M., Hoehn, J., Benoit, S., Benoit, J. et al. Validation of corona-score for rapid identification of SARS-CoV-2 infections in patiens seeking emergency departement care in the United States. Clin. Chem. Lab. Med., 2020, 58(12), e311-e313.
Santos-Lozano, A., Calvo-Boyero, F., López-Jiménez, A., Cueto-Felgueroso, C., Castillo-García, A. Can routine laboratory variables predict survival in COVID-19? An artificial neural network-based approach. Clin. Chem. Lab. Med., 2020, 58(12), e299-e302.
Das, B. From routine analytes to cytokines. Diagnosticians deliver value to COVID-19, diagnosis, management and risk assessment. Clin. Lab. News, 2020.

Labels

Clinical biochemistry Nuclear medicine Nutritive therapist

EDITORIAL

Quantitative determination of hemoglobin in stool - preanalytical and analytical aspects

Overview of biomarkers of synovial fluid in joint diseases

Measurement of anti-SARS-CoV-2 antibodies nucleocapsid versus spike, ECLIA versus ELISA

Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře: POCT metody v ordinaci praktického lékaře

Doporučení České společnosti klinické biochemie ČLS JEP k využití nádorových markerů v klinické praxi

Article was published in

Clinical Biochemistry and Metabolism

2021 Issue 1